Stock Analysts

ON Semiconductor Beats on Q1 Earnings

ON Semiconductor ( ONNN ) reported first-quarter 2014 earnings of 17 cents, exceeding the Zacks Consensus Estimate by 2 cents. Revenues ON Semi reported revenues of $706.5 million, down 0.4% sequentially but up 6.9% year over year. Reported revenues were at the lower end of the company’s expected range of $695.0–$725.0 million and below the Zacks Consensus Estimate of $712.0 million. […]

Stock Analysts

RBS Rallies on Encouraging Q1 Earnings

The Royal Bank of Scotland Group plc ’s ( RBS ) share price jumped 7.89% to $11.21, following the impressive earnings in first-quarter 2014. First-quarter 2014 profit from continuing operations came in at £1.28 billion ($2.12 billion), rising more than twofold from £476 million ($739.4 million) in the prior-year quarter. Results were positively driven by lower loan impairment losses and reduced operating expenses. […]

Mergers & Acquisitions

Freedom Mortgage Announces the Acquisition of BluFi Lending

Freedom Mortgage Announces the Acquisition of BluFi Lending BluFi Lending will become part of Freedom Mortgage; All branches will be rebranded under the Freedom Mortgage name expanding Freedom Mortgage’s retail footprint in Western U.S. PR Newswire MOUNT LAUREL, N.J., May 5, 2014 MOUNT LAUREL, N.J. , May 5, 2014 /PRNewswire/ — Freedom Mortgage Corporation , a privately held, full-service residential mortgage lender licensed in all 50 states, has purchased the assets of BluFi Lending, a direct mortgage lender with branches in California and Nevada […]

Technicals

Altera (ALTR) Enters Oversold Territory – Tale of the Tape

Altera Corporation’s ( ALTR ) share price has entered into oversold territory with an RSI value of 28.8. The Zacks Consensus Estimate for Altera for the full year period has improved 3 cents over the past two months to $1.51 per share. Currently, Altera has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on ( ALTR ) after its recent drop […]

Technicals

Why Alexion Pharmaceuticals (ALXN) could be an Impressive Growth Stock – Tale of the Tape

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses. One such company that might be well-positioned for future earnings growth is Alexion Pharmaceuticals, Inc. […]

Technicals

Auspex (ASPX) is now in Oversold Territory – Tale of the Tape

Auspex Pharmaceuticals Inc ’s ( ASPX ) share price has entered into oversold territory with an RSI value of 28.1. The Zacks Consensus Estimate for Auspex for the full year period has improved 2 cents over the past two months to $-1.92 per share. Currently, Auspex has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on ( ASPX ) after its recent drop […]

Technicals

Safeguard Scientifics, Inc. (SFE): An Off-the-Radar Potential Winner – Tale of the Tape

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach. So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision […]

Mergers & Acquisitions

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 — Companies Schedule Shareholder Meetings for June 17, 2014 — PR Newswire DUBLIN and NEW YORK, May 5, 2014 DUBLIN and NEW YORK , May 5, 2014 /PRNewswire/ — Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced that the registration statement on Form S-4 filed with the U.S. […]